The aim of this study was to determine the role of KIR+ CD8+ T cells in cancer immune surveillance by analyzing the frequency of these cells in peripheral blood of patients with different types of solid cancers at diagnosis, and their association with specific KIR/HLA-ligand interactions and patient survival. The gene discussed is CD8A; the disease is cancer.